NO20030073L - Medikamentleveringssystem for medikamenter som er lite vannopplöselige - Google Patents
Medikamentleveringssystem for medikamenter som er lite vannopplöseligeInfo
- Publication number
- NO20030073L NO20030073L NO20030073A NO20030073A NO20030073L NO 20030073 L NO20030073 L NO 20030073L NO 20030073 A NO20030073 A NO 20030073A NO 20030073 A NO20030073 A NO 20030073A NO 20030073 L NO20030073 L NO 20030073L
- Authority
- NO
- Norway
- Prior art keywords
- water soluble
- drugs
- delivery system
- drug delivery
- hydrogels
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Colloid Chemistry (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21662700P | 2000-07-07 | 2000-07-07 | |
US25238900P | 2000-11-21 | 2000-11-21 | |
PCT/CA2001/000993 WO2002003962A2 (en) | 2000-07-07 | 2001-07-06 | Drug delivery system for poorly water soluble drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030073D0 NO20030073D0 (no) | 2003-01-07 |
NO20030073L true NO20030073L (no) | 2003-03-06 |
Family
ID=26911183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030073A NO20030073L (no) | 2000-07-07 | 2003-01-07 | Medikamentleveringssystem for medikamenter som er lite vannopplöselige |
Country Status (12)
Country | Link |
---|---|
US (1) | US20030157171A1 (ja) |
EP (1) | EP1299089B1 (ja) |
JP (1) | JP2004502722A (ja) |
AT (1) | ATE322891T1 (ja) |
AU (1) | AU2001272262A1 (ja) |
BR (1) | BR0112258A (ja) |
CA (1) | CA2415081A1 (ja) |
DE (1) | DE60118742D1 (ja) |
IL (1) | IL153814A0 (ja) |
NO (1) | NO20030073L (ja) |
NZ (1) | NZ523418A (ja) |
WO (1) | WO2002003962A2 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005062041A1 (en) * | 2003-12-24 | 2005-07-07 | Astrazeneca Ab | Pharmaceutical dissolution testing using a non-ionic surfactant |
IL160095A0 (en) * | 2004-01-28 | 2004-06-20 | Yissum Res Dev Co | Formulations for poorly soluble drugs |
EP1868587A2 (en) * | 2005-04-08 | 2007-12-26 | Abbott Laboratories | Pharmaceutical formulations comprising fenofibric acid and/or its salts |
WO2007036044A1 (en) * | 2005-09-28 | 2007-04-05 | Dnp Canada Inc. | Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia |
WO2007056205A2 (en) * | 2005-11-04 | 2007-05-18 | Eastman Chemical Company | Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents |
BRPI0710578B1 (pt) | 2006-04-05 | 2016-11-29 | Woodland Biofuels Inc | método de produção de etanol a partir de gás de síntese |
US20100129423A1 (en) * | 2007-04-19 | 2010-05-27 | Medovent Gmbh | Device made at least partially of n-acetylchitosan with controlled biodissolution |
WO2012034079A2 (en) | 2010-09-09 | 2012-03-15 | Micell Technologies, Inc. | Macrolide dosage forms |
AU2012291631A1 (en) | 2011-08-01 | 2014-02-27 | Sun Pharmaceutical Industries Limited | Dissolution enhanced controlled drug delivery system for poorly water soluble drugs |
CN103315960A (zh) * | 2012-03-19 | 2013-09-25 | 胡容峰 | 基于球晶技术固体自微乳及其制备方法 |
WO2019064231A1 (en) * | 2017-09-27 | 2019-04-04 | Association For The Advancement Of Tissue Engineering And Cell Based Technologies & Therapies (A4Tec) - Associação | HIGH MOLECULAR WEIGHT CHITOSAN, METHOD FOR PRODUCING THE SAME AND USES THEREOF |
KR102407470B1 (ko) * | 2021-08-09 | 2022-06-10 | 인제대학교 산학협력단 | 하이드로겔에 담지된 약물의 방출량 검출 방법 |
CN114515268B (zh) * | 2022-02-21 | 2024-06-21 | 上海宣泰医药科技股份有限公司 | 熊去氧胆酸药物组合物及其制备方法和药物制剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620706A (en) * | 1995-04-10 | 1997-04-15 | Universite De Sherbrooke | Polyionic insoluble hydrogels comprising xanthan and chitosan |
CA2243619A1 (fr) * | 1998-07-17 | 2000-01-17 | Universite De Sherbrooke | Hydrogels polyioniques a base de xanthane et chitosane pour stabilisation et relargage controle des vitamines |
-
2001
- 2001-07-06 WO PCT/CA2001/000993 patent/WO2002003962A2/en active IP Right Grant
- 2001-07-06 EP EP01951278A patent/EP1299089B1/en not_active Expired - Lifetime
- 2001-07-06 AU AU2001272262A patent/AU2001272262A1/en not_active Abandoned
- 2001-07-06 JP JP2002508417A patent/JP2004502722A/ja not_active Withdrawn
- 2001-07-06 IL IL15381401A patent/IL153814A0/xx unknown
- 2001-07-06 AT AT01951278T patent/ATE322891T1/de not_active IP Right Cessation
- 2001-07-06 US US10/332,251 patent/US20030157171A1/en not_active Abandoned
- 2001-07-06 NZ NZ523418A patent/NZ523418A/en unknown
- 2001-07-06 CA CA002415081A patent/CA2415081A1/en not_active Abandoned
- 2001-07-06 BR BR0112258-4A patent/BR0112258A/pt not_active IP Right Cessation
- 2001-07-06 DE DE60118742T patent/DE60118742D1/de not_active Expired - Lifetime
-
2003
- 2003-01-07 NO NO20030073A patent/NO20030073L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20030157171A1 (en) | 2003-08-21 |
WO2002003962A3 (en) | 2002-06-13 |
NO20030073D0 (no) | 2003-01-07 |
NZ523418A (en) | 2004-09-24 |
JP2004502722A (ja) | 2004-01-29 |
BR0112258A (pt) | 2003-06-24 |
IL153814A0 (en) | 2003-07-31 |
DE60118742D1 (de) | 2006-05-24 |
AU2001272262A1 (en) | 2002-01-21 |
EP1299089A2 (en) | 2003-04-09 |
WO2002003962A2 (en) | 2002-01-17 |
EP1299089B1 (en) | 2006-04-12 |
CA2415081A1 (en) | 2002-01-17 |
ATE322891T1 (de) | 2006-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20030073L (no) | Medikamentleveringssystem for medikamenter som er lite vannopplöselige | |
FR16C0030I1 (fr) | Glycoproteine d'hyaluronidase soluble (shasegp), son procede de preparation, utilisations et compositions pharmaceutiques le comportant | |
CY1110878T1 (el) | Διαδικασιες για την μετρηση της ισχυος του glatiramer acetate | |
NO20014035L (no) | System for oral administrasjon av medikament | |
MXPA03007837A (es) | Composiciones para suministrar bisfosfonatos. | |
WO2002100437A3 (en) | Ophthalmic compositions comprising hyaluronic acid | |
SE9904505D0 (sv) | Novel compounds | |
MXPA02011458A (es) | Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos. | |
SG147286A1 (en) | Manufacture of polyglumate-therapeutic agent conjugates | |
ATE389385T1 (de) | Ophthalmische depot-formulierungen zur periokkularen oder subkonjunktivalen verabreichung | |
YU7804A (sh) | Stabilni polimorf flibanserina,postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova | |
MXPA02009275A (es) | Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos. | |
PL1643833T3 (pl) | Formulacje agrochemiczne | |
NO20014101L (no) | Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte | |
EA200400455A1 (ru) | Способ приготовления быстрорастворимой дозировочной формы | |
MY134167A (en) | Biphenylcarboxamides useful as lipid lowering agents | |
DE69924004D1 (de) | Verabreichungssystem für wasserunlösliche arzneistoffe | |
WO2003063824A3 (en) | Pharmaceutical composition | |
MY149864A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
DE60209359D1 (de) | Lösungsmittelverklebungsverfahren | |
AU2003256882A1 (en) | Methods of drug delivery using sulphated chitinous polymers | |
AU7599900A (en) | Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles | |
EP1283042A4 (en) | AQUEOUS FLUID PREPARATION | |
MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
AP2003002897A0 (en) | Processes and intermediates for preparing benzyl epoxides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |